英文字典中文字典Word104.com



中文字典辭典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z   







請輸入英文單字,中文詞皆可:

regulus    
n. 獅子座的一等星,熔渣

獅子座的一等星,熔渣

Regulus
n 1: the brightest star in Leo
2: a genus of birds of the family Sylviidae including kinglets
[synonym: {Regulus}, {genus Regulus}]

Regulus \Reg"u*lus\ (-l?s), n.; pl. E. {Reguluses} (-?z), L.
{Reguli} (-l?). [L., a petty king, prince, dim. of rex,
regis, a king: cf. F. r['e]gule. See {Regal}.]
1. A petty king; a ruler of little power or consequence.
[1913 Webster]

2. (Chem. & Metal.) The button, globule, or mass of metal, in
a more or less impure state, which forms in the bottom of
the crucible in smelting and reduction of ores.
[1913 Webster]

Note: The name was introduced by the alchemists, and applied
by them in the first instance to antimony. It signifies
little king; and from the facility with which antimony
alloyed with gold, these empirical philosophers had
great hopes that this metal, antimony, would lead them
to the discovery of the philosopher's stone. --Ure.
[1913 Webster]

3. (Astron.) A star of the first magnitude in the
constellation Leo; -- called also the {Lion's Heart}.
[1913 Webster]

請選擇你想看的字典辭典:
單詞字典翻譯
regulus查看 regulus 在Google字典中的解釋Google英翻中〔查看〕
regulus查看 regulus 在Yahoo字典中的解釋Yahoo英翻中〔查看〕





安裝中文字典英文字典查詢工具!


中文字典英文字典工具:
選擇顏色:
輸入中英文單字

































































英文字典中文字典相關資料:
  • Regulus - Wikipedia
    Regulus is the brightest object in the constellation Leo and one of the brightest stars in the night sky It has the Bayer designation designated α Leonis, which is Latinized to Alpha Leonis, and abbreviated Alpha Leo or α Leo
  • Regulus Therapeutics Enters into Agreement to be Acquired by . . .
    SAN DIEGO, April 30, 2025 PRNewswire -- Regulus Therapeutics Inc (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs (the "Company" or "Regulus"), today announced that it has entered into an agreement and plan of merger with Novartis AG ("Novartis") and an indirect
  • Regulus Therapeutics
    Our pipeline programs target kidney diseases of high unmet need, including ADPKD We are targeting the underlying biology of these diseases with a novel and potentially powerful approach: MicroRNA-based therapeutics News
  • Novartis announces commencement of tender offer to acquire . . .
    Basel, May 27, 2025 - Novartis today announced that Redwood Merger Sub Inc , a Delaware corporation and an indirect wholly owned subsidiary of Novartis (“Purchaser”), has commenced a tender offer to acquire all of the outstanding shares of common stock, par value $0 001 per share (the “Shares”), of Regulus Therapeutics Inc , a Delaware
  • Novartis pays $800M to buy Regulus for phase 3-ready kidney drug
    Novartis has committed another $1 7 billion to its ambition to become a kidney disease leader The Swiss drugmaker is making the outlay, around half of which is upfront, to buy Regulus
  • Novartis grabs kidney drug developer Regulus in $1. 7bn deal
    Novartis has reached an agreement to buy Regulus Therapeutics and its experimental therapy for autosomal dominant polycystic kidney disease (ADPKD) for $800 million upfront in a deal that could
  • Regulus Therapeutics Inc. (RGLS) Stock Price, News, Quote . . .
    Regulus Therapeutics Inc , a clinical-stage biopharmaceutical company, engages in the discovery and development of drugs that targets microRNAs to treat a range of diseases in the United States
  • Novartis to acquire Regulus Therapeutics and farabursen, an . . .
    Basel, April 30, 2025 – Novartis today announced that it has entered into an agreement to acquire Regulus Therapeutics, a San Diego-based, publicly traded (Nasdaq: RGLS) clinical-stage biopharmaceutical company focused on developing microRNA therapeutics
  • Regulus Therapeutics Announces Positive Clinical and . . .
    Topline data from an interim analysis of the fourth cohort of its Phase 1b Multiple-Ascending Dose (MAD) clinical trial showed continued mechanistic dose response Exploratory results of imaging-based biomarkers continued to show reduction in height-adjusted total kidney volume (htTKV) growth rate
  • Watch the stunning Mars and Regulus conjunction today with . . .
    During conjunction, both Mars and Regulus — the 21st brightest star in the night sky — will shine at 1 4 magnitude Although virtually equal in brightness, the two celestial objects differ





中文字典-英文字典  2005-2009

|中文姓名英譯,姓名翻譯 |简体中文英文字典